Visualitza HVH - Articles científics per autor "Ohtsu, Atsushi"
Ara mostrant els elements 1-4 d 4
-
Effect of trifluridine/tipiracil in patients treated in RECOURSE by prognostic factors at baseline: an exploratory analysis
Tabernero Caturla, Josep; Argilés Martinez, Guillem; Sobrero, Alberto; Borg, Christophe; Ohtsu, Atsushi; Mayer, Robert (BMJ, 2020-08-19) -
Neutropenia and survival outcomes in metastatic colorectal cancer patients treated with trifluridine/tipiracil in the RECOURSE and J003 trials
Yoshino, T.; Cleary, J. M.; Van Cutsem, Eric; Mayer, Robert; Ohtsu, Atsushi; Shinozaki, E.; Argilés Martinez, Guillem (Elsevier, 2020-01) -
Pertuzumab, trastuzumab, and chemotherapy in HER2-positive gastric/gastroesophageal junction cancer: end-of-study analysis of the JACOB phase III randomized clinical trial
Tabernero Caturla, Josep; Hof, Paulo M.; Ohtsu, Atsushi; Shah, Manish A.; Siddiqui, Asna; Shen, Lin (Springer, 2023-01) -
Pooled safety analysis from phase III studies of trifluridine/tipiracil in patients with metastatic gastric or gastroesophageal junction cancer and metastatic colorectal cancer
Van Cutsem, Eric; Hochster, Howard S.; Shitara, Kohei; Mayer, Robert; Ohtsu, Atsushi; Falcone, Alfredo; Tabernero Caturla, Josep (Elsevier, 2022-12)